[Skip to Content]
[Skip to Content Landing]
March 14, 2017

Management of Type 2 Diabetes in 2017: Getting to Goal

Author Affiliations
  • 1Center for Women’s Health Research, Anschutz Medical Center, University of Colorado, Denver
  • 2Denver VA Medical Center, Denver, Colorado
  • 3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
  • 4Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts
JAMA. 2017;317(10):1015-1016. doi:10.1001/jama.2017.0241

More than 29 million people in the United States and 420 million globally have diabetes, with a projected global prevalence of 642 million by 2040.1,2 This accelerating pandemic comes with high personal and financial costs to the individual, society, and the economy. The expanding number of antihyperglycemic medication options for type 2 diabetes, often involving different mechanisms of action and safety profiles, can be a challenge for clinicians, and the increasing complexity of diabetes management requires a well-informed strategy for prevention and treatment of this disease.